Skip to main content
logo
HEM Pharma Inc. (KOSDAQ:376270)
South Korea flag South Korea · Delayed Price · Currency is KRW
33,900
0.00 (0.00%)
At close: Sep 18, 2026

HEM Pharma Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Revenue
16,14212,97915,067
Revenue Growth
1.54%-13.86%-
Gross Profit
2,048624.021,616
Operating Income
-17,020-15,583-7,682
Net Income
-20,873-23,842-7,646
Earnings Per Share
-2925.70-3389.26-1203.00
EPS Growth
---

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Cash & Investments
9,55513,78511,274
Total Debt
19,31619,2557,821
Net Cash (Debt)
-9,761-5,4703,453
Net Cash Growth
---
Net Cash Per Share
-1368.20-777.61543.32

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Operating Cash Flow
-7,423-8,345-7,680
Capital Expenditures
-11,233-9,755-4,687
Free Cash Flow
-18,656-18,100-12,367
Free Cash Flow Growth
---

Margins
Chart
Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Gross Margin
12.69%4.81%10.72%
Operating Margin
-105.44%-120.06%-50.98%
Pretax Margin
-148.21%-182.75%-50.51%
Profit Margin
-129.31%-183.69%-50.75%
FCF Margin
-115.57%-139.45%-82.08%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
PS Ratio
15.1425.237.62